Література. 
Ознаки тромбоутворення та їх зв’язок із морфофункціональними характеристиками міокарда у хворих із персистуючою формою фібриляції-тріпотіння передсердь

1. Ассоциация кардиологов Украины. Диагностика и лечение фибрилляции предсердий / Рекомендации рабочей группы по нарушениям сердечного ритма Ассоциации кардиологов Украины. К., 2009. 42 с.

2. Collins L., Silverman D., Douglas P., Manning W. Cardioversion of non-rheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution // Circulation. 1995. Vol. 92. P. 160−163.

3. Donal E., Yamada H., Leclercq C., Herpin D. The left atrial appendage, a small, blind-ended structure: a review of its echocardiographic evaluation and its clinical role // Chest. 2005. Vol. 128 (3). P. 1853−1862.

4. Fatkin D., Kelley R., Fenely M. Relations between left atrial appendage blood flow, spontaneous echocardiographic contrast and thromboembolic risk in vivo // J. Amer. Coll. Cardiol. 1994. Vol. 23. P. 961−969.

5. Goldman M. The management of chronic atrial fibrillation // Prog. Cardiovasc. Dis. 1960. Vol. 2. P. 465−479.

6. Klein A., Murray R., Grimm R. Role of transesophageal echocardiography guided cardioversion of patients with atrial fibrillation // J. Amer. Coll. Cardiol. 2001. Vol. 37(3). P. 691−704.

7. Lang M., Bierig M., Devereux R. et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology // J. Amer. Soc. Echocardiogr. 2005. Vol. 18. P. 1440−1463.

8. Leung D., Black I., Cranney G. et al. Prognostic implications of left atrial spontaneous contrast in nonvalvular atrial fibrillation // J. Amer. Coll. Cardiol. 1994. Vol. 24. P. 755−761.

9. Leung D., Davidson P., Cranney G., Walsh W. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram // Amer. J. Cardiol. 1997. Vol. 79. P. 626−629.

10. Manning W., Silverman D., Keighley K. et al. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation // Arch. Intern. Med. 1995. Vol. 155. P. 2193−2197.

11. Nagueh S., Appleton C., Gillebert T. et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography // J. Amer. Soc. Echocardiogr. 2009. Vol. 22, № 2. P. 107−133.

12. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. Stroke Prevention in Atrial Fibrillation Investigators // J. Stroke Cerebrovasc. Disorders. 1995. Vol. 5. P. 147−157.

13. Sherif F., Issam M., Helen A. et al. Doppler Estimation of Left Ventricular Filling Pressure in Sinus Tachycardia. A New Application of Tissue Doppler Imaging // Circulation. 1998. Vol. 98. P. 1644−1650.

14. SPAF III Investigators. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrilation Investigators Committee on Echocardiography // Ann. Intern. Med. 1998. Vol. 128. P. 639−647.

15. Vahanian H., Baumgartner I., Bax J. et al. Guidelines on the management of valvular heart disease. The task force on the management of valvular heart disease of the European society of cardiology // Eur. Heart J. 2007. Vol. 28. P. 230−268.